MarkRichardSchleissMD

Professor, Pediatrics, University of Minnesota Medical School

Dr. Schleiss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2001 6th Street SE
3rd Floor
Minneapolis, MN 55455
Phone+1 612-624-1112

Fax+1 612-626-9924

University of WashingtonFellowship, Pediatric Infectious Diseases, 1988 - 1991
Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 1985 - 1988
Oregon Health and Science University School of MedicineClass of 1985

PubMed

An Unusual Soft-Tissue Infection in the "Land of 10,000 Lakes".
Julia R Klein, Haejin Hwang, Marijke Decuir, Evann E Hilt, Mark R Schleiss
Clinical Pediatrics. 2025-01-30
A vaccine against cytomegalovirus: how close are we?
Sallie R Permar, Mark R Schleiss, Stanley A Plotkin
The Journal of Clinical Investigation. 2025-01-02
Universal newborn screening for congenital cytomegalovirus infection.
Mark R Schleiss, Daniel Blázquez-Gamero
The Lancet. Child & Adolescent Health. 2025-01-01

Population-Based Screening Program Identifies and Manages Congenital Cytomegalovirus in Ontario NewbornsJanuary 22nd, 2025
CMV Screening: The Change in MN Affecting Every Newborn in the StateApril 5th, 2023
Congenital Cytomegalovirus Declined in Wake of COVID-19September 13th, 2022
Join now to see all

If You Don't Pass, ScreenMinnesota Vikings CHIP Grant2016–2019
Viral Immunomodulation And Rational CMV Vaccine DesignEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2012
Bedside-To-Bench Research Training For Pediatric Infectious Diseases FellowsEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
Vaccines For Prevention Of Experimental Congenital CMVEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2009
Transgenic Plant-Derived CMV Glycoprotein B VaccineNational Institute Of Allergy And Infectious Diseases2006–2007
Novel Strategy For Animal Model Testing Of HCMV VaccinesNational Institute Of Allergy And Infectious Diseases2006–2007
Viral Immunomodulation And Rational CMV Vaccine DesignEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2004
Vaccines For Prevention Of Experimental Congenital CMVEunice Kennedy Shriver National Institute Of Child Health &Human Development2000–2003
Gpcmv Structural/Regulatory Proteins--Molecular AnalysisNational Institute Of Allergy And Infectious Diseases1994–1996